Surprisingly, businesswire.com at times has useful items on CRC

coloCan
coloCan Member Posts: 1,944 Member
edited March 2014 in Colorectal Cancer #1
such as that of 1/18 pertaining to a Phase I clinicl trial at Johns Hopkins Univ Hosp, Duke Univ Med Center and North Shore Long Island Jewish Med Center for NPC-1C-Ensituximab--

"Data on Neogenix Oncology's Novel Therapeutic Antibody NPC-1C.........."



Today, this site carried an article titled "Merck Serono: Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With Folfox", which some might find informative.......steve

Comments

  • AnneCan
    AnneCan Member Posts: 3,673 Member
    #2
    Hey Steve!
    You got me at "long-term survival benefit". Thanks!
  • pete43lost_at_sea
    pete43lost_at_sea Member Posts: 3,900 Member
    #3
    Very interesting read thanks
    Enjoyed learning about this, thanks for posting it hear.
    cheers,
    Pete

Discussion Boards